|
Post by whale1r1 on Oct 6, 2017 22:13:39 GMT -5
In case seeking alpha took down my post challenging the "hit piece" author who bashed MNKD.. I figure that it would only be appropriate to raise the stakes.
Well as a long time shareholder and supporter of Al Mann, let's just clarify the record right now.
People who bet against Al Mann in the past lost big. Time will tell who is the foolish one here and I am willing to put my money where my mouth is on this one. Feel free to contact me and have a heart filled discussion of who is willing to back up the or statement with a larger percentage of their assets in MNKD. So in that note, since your so confident it will fail, let's see you back up that statement with over 50% of your assets shorting MNKD. I will back it up by holding 50% or more of my assets in MNKD... Let's see who is willing to walk the walk versus talking the talk.
|
|
|
Post by mytakeonit on Oct 7, 2017 0:32:15 GMT -5
Forget showing statements ... send your betting $$$ to me and I'll hold it for you. You all know that you can trust me!
(Maybe get that Gambling Cowboy sooner than I thought.) LOL
BTW, new name will be MNKD's Gambling Cowboy ... you will get a free inhaler when ordering your drinks or dinner. First time patrons will get 2 or 3 free boluses ... because we know you will be at the "Parrrrttty" for more than 3 hours FOR SURE.
|
|
|
Post by sportsrancho on Oct 7, 2017 7:20:18 GMT -5
Party at $20:-)
|
|
Deleted
Deleted Member
Posts: 0
|
Post by Deleted on Oct 7, 2017 7:28:59 GMT -5
Feroldi intentionally misrepresents facts and statements. Case in point : "Why did MannKinds CEO publicly admit Afrezza had a minor issue with efficacy for their users? You do understand..the lack of efficacy means the product doesn'twork as advertised?"
When I ask him to provide the exact statement along with a link he ignores me.
|
|
|
Post by promann on Oct 7, 2017 7:30:15 GMT -5
Sports I believe that’s going to be this year. We might as well set a date. How’s about we all get together and go to a conference call we could be the rowdy crowd clapping and hooting. 👏
|
|
|
Post by brotherm1 on Oct 7, 2017 8:21:15 GMT -5
Feroldi intentionally misrepresents facts and statements. Case in point : "Why did MannKinds CEO publicly admit Afrezza had a minor issue with efficacy for their users? You do understand..the lack of efficacy means the product doesn'twork as advertised?" When I ask him to provide the exact statement along with a link he ignores me. HAD a minor issue NOT HAS is what Mike said as I recall. Mike was referring to some patients and dose amounts and implied the label change would correct that. Someone correct me if I am wrong but this by memory is what I recall Mike saying. So if I am correct on this, Feroldi is intentionally misrepresenting and would need majorly corrected at the least.
|
|
|
Post by mnkdfann on Oct 7, 2017 8:36:06 GMT -5
Feroldi intentionally misrepresents facts and statements. Case in point : "Why did MannKinds CEO publicly admit Afrezza had a minor issue with efficacy for their users? You do understand..the lack of efficacy means the product doesn'twork as advertised?" When I ask him to provide the exact statement along with a link he ignores me. Allow me to play Devil's Advocate here and say that, given LFD has posted the link / referenced the quote many times over the past 10 months or so, and it appears in a conference call all investors should be familiar with, I can sort of understand why he ignores your request. How many times does he have to do it? (BTW, Castagna was CCO when he made that comment about efficacy, he is CEO now.) It took me 5 seconds to find it with a simple google search. Here is LFD quoting the comment: seekingalpha.com/article/4042502-mannkind-saga-smoking-guns"[W]e have learned that patients dropped off Afrezza for two reasons, one was because of cost and two was because of efficacy. And there are other reasons they dropped out, but the two predominant reasons are based on these two factors." Here is the transcript for the conference call in which Castagna made the comment, if you want to see it in full context: seekingalpha.com/article/4021887-mannkinds-mnkd-ceo-matthew-pfeffer-q3-2016-results-earnings-call-transcript?part=single
|
|
Deleted
Deleted Member
Posts: 0
|
Post by Deleted on Oct 7, 2017 9:25:23 GMT -5
mnkdfann using a lower dose of Afrezza than required is not what I would describe as an efficacy issue. In my opinion Castagna should have said under-dosed. Anyway, one gets the picture, negative spin from the usual suspects.
|
|
|
Post by mnkdfann on Oct 7, 2017 9:57:37 GMT -5
mnkdfann using a lower dose of Afrezza than required is not what I would describe as an efficacy issue. To be clear, in case anyone may be confused, I never said it was. I was just being a Boy Scout and providing requested links / sources as a community service.
|
|
|
Post by itellthefuture777 on Oct 7, 2017 10:06:24 GMT -5
As far as the author..if he thinks Mike can't win with Afrezza then he probably doesn't think ferrari's can't beat yugo's..guys like that you can show them an actual race..where the yugo..is left in the dust...and the guy will say...the ferarri is less safe...then you show him it is bullet proof..seatbelts..completely safe..he will say..oh..well..its not..soft..(starting to crack now he says)..but its not pink..its not fuzzy..it's not my Doobby bear! Mommyeee! (Doobby a stuffed animal he tragically lost in a wet bed incident years ago) You can now find him sucking his thumb in a corner..complaining just about everything...which is how he got the office nickname: Thumb D... (Hey..I am just guessing that's why they call him that..reasons may vary)
|
|
|
Post by bioexec25 on Oct 7, 2017 10:20:52 GMT -5
Dinner party at $20, a Mnkd cruise at $50.
|
|
|
Post by sportsrancho on Oct 7, 2017 10:55:17 GMT -5
Dinner party at $20, a Mnkd cruise at $50. Perfect! It used to be Vegas... but not so into that at this point.
|
|
|
Post by straightly on Oct 7, 2017 11:05:54 GMT -5
Feroldi intentionally misrepresents facts and statements. Case in point : "Why did MannKinds CEO publicly admit Afrezza had a minor issue with efficacy for their users? You do understand..the lack of efficacy means the product doesn'twork as advertised?" When I ask him to provide the exact statement along with a link he ignores me. Feroldi is purposely trying to muddy the water. The fact that Afrezza gets out of the system faster is an advantage, NOT an in-effeciency. So, yes, after Afrezza has done its job lowering one's blood suger level, it is out and stops "working". It is like a hammer and a sledgehammer with a nail, one strike of sledgehammer on the head, if one control one's strength very accurately, it is done. With a hammer, quite often, it is also done. However, a sledge hammer may miss judge the strength needed and make a hole in the wall. Sometimes, it may miss the nail completely AND make a big hole in the wall with the nail still stcking out. With a hammer, it is not problem free either. One problem is one might have a hammer sized too small for the nail. Another might be that one has to strike the nail twice before it is done. For some, striking it more than once IS inconvenient. FDA made us to show that our hammer is effective, we ended up proving that it is non inferior. But that was because the definition of efficacy is mis-guided and missed the head of nail completely. When one's blood suger level is not high, such 'efficacy' is couter productive and dangerous. The long delay AND long tail of the other insulines make it very hard to measure and time correctly and that is why many that are on insulin have to settle with elevated A1C. The nails are still sticking out, but we must not risk knocking down the wall. We have known Afrezza is more effective for a long time, but in a totally different and disruptive way. However, we were not allowed to say that to the doctors, or the whole world for that matter. So Afrezza is much more effective but only if you measure efficacy correctly using measures such as time the range or achieved A1C level. If you are measuring the brutal force, yes Afrezza is less brutal. Feroldi is purposely trying to avoid this point. My question to the board is: do you think we should write an SA article to counter his? Yes, his is not worthy of a counter, but those mis-guided readers do desearve to know the WHOLE truth. One does has to go through SA gate for that though.
|
|
|
Post by peppy on Oct 7, 2017 11:09:18 GMT -5
I put in a comment, it is under review.....
|
|
|
Post by mnholdem on Oct 7, 2017 11:12:43 GMT -5
Frankly, I just wish folks here would not post the links. Feraldi gets paid every time someone clicks on and that fact alone is why some of these pundits write outrageous articles with provocative titles. It's click bait. Don't take the bait.
|
|